MedElevator Войти в исследования
← Поиск публикаций

DOI 10.55563/clinexprheumatol/omk0if

Медицинская библиотека · Clinical and experimental rheumatology · 2026

Long-term low dose glucocorticoid therapy in rheumatoid arthritis: a systematic review with meta-analysis on cardiovascular effects.

Gotelli Emanuele, Campitiello Rosanna, Hysa Elvis, Soldano Stefano, Pizzorni Carmen, Paolino Sabrina, Sulli Alberto, Smith Vanessa, Cutolo Maurizio

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

OBJECTIVE

Recently, a vaccine with the capacity to protect against serogroup B meningococcal (MenB) disease received a positive opinion of the European Medicines Agency. Previously, such a vaccine was estimated to be cost-effective. However, since then, the MenB disease incidence has declined drastically in the Netherlands. Therefore, we re-assessed the potential incremental cost-effectiveness ratio (ICER) of vaccinating infants in the Netherlands with a MenB vaccine.

RESULTS

Routine infant vaccination (2, 3, 4+11 mo) could prevent 39 cases of MenB disease in a single birth cohort, corresponding to a total gain of 133 quality-adjusted life years (QALYs). However, this strategy is unlikely to be cost-effective if the vaccine costs €40 per dose (€243,778 per QALY). At a disease incidence of 5.7 per 100,000 person-years or a vaccine price of €10 per dose including administration costs, the ICER becomes more acceptable and remains below a threshold of €50,000 per QALY.

METHODS

A cohort of 185,000 Dutch newborns was followed in a Markov model to compare routine vaccination against MenB disease with no vaccination. The ICER was estimated for different disease incidences. The study was performed from a societal perspective.

CONCLUSIONS

At the current low level of disease incidence, introduction of routine infant vaccination, following a 2, 3, 4+11 mo schedule, against MenB disease is unlikely cost-effective in the Netherlands. If the MenB disease incidence increases or the vaccine price is substantially lower than €40, routine infant vaccination has the potential to be cost-effective.

Для цитирования: Gotelli Emanuele, Campitiello Rosanna, Hysa Elvis, Soldano Stefano, Pizzorni Carmen, Paolino Sabrina, Sulli Alberto, Smith Vanessa, Cutolo Maurizio. Long-term low dose glucocorticoid therapy in rheumatoid arthritis: a systematic review with meta-analysis on cardiovascular effects.. Clinical and experimental rheumatology. 2026. DOI: 10.55563/clinexprheumatol/omk0if.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.